TransEnterix, Inc.
(NYSE Amex Equities : TRXC)

( )
TRXC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Commercial Services » Miscellaneous Commercial Services
MARAMarathon Patent Group, Inc. -12.59%32.010.5%$989.97m
ETSYEtsy, Inc. -5.04%198.107.5%$542.77m
TALTAL Education Group -1.64%75.150.8%$238.69m
CHGGChegg, Inc. -1.14%88.6513.5%$207.70m
FLTFLEETCOR Technologies, Inc. -1.29%278.673.6%$199.09m
EFXEquifax, Inc. -1.76%164.102.0%$161.52m
CPRTCopart, Inc. -2.71%104.114.4%$126.27m
BAHBooz Allen Hamilton Holding Corp. -2.54%76.672.0%$126.19m
PAGSPagSeguro Digital Ltd. -5.41%52.630.0%$120.51m
PRAHPRA Health Sciences, Inc. -1.33%142.852.4%$114.54m
CDAYCeridian HCM Holding, Inc. -3.27%82.720.0%$108.67m
TRXCTransEnterix, Inc. -10.79%4.055.3%$101.94m
ITGartner, Inc. -2.56%177.962.5%$99.71m
CRLCharles River Laboratories International, Inc. -3.60%268.254.5%$94.84m
BRBroadridge Financial Solutions, Inc. -1.84%139.281.5%$91.78m

Company Profile

TransEnterix, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.